The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease

被引:93
|
作者
Mouzaki, Marialena [1 ]
Allard, Johane P. [2 ]
机构
[1] Hosp Sick Children, Dept Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada
关键词
NAFLD; fatty liver; nutrition; diet; obesity; INDUCED INSULIN-RESISTANCE; INDUCED HEPATIC STEATOSIS; LIFE-STYLE INTERVENTION; PHYSICAL-ACTIVITY; VITAMIN-E; GLYCEMIC INDEX; IRON OVERLOAD; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; DIETARY REQUIREMENTS;
D O I
10.1097/MCG.0b013e31824cf51e
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in adults and children and is currently the third most common indication for liver transplantation in North America. Its pathogenesis is thought to be secondary to multiple "hits" derived from the dietary components, adipose tissue, immune system, and intestinal microbiota. Lack of physical activity may contribute as well. Nutrients may exert their effect directly or through alteration of the intestinal microbiota. Research focusing on specific dietary components predisposing to NAFLD has shown conflicting results. Total energy intake, and macronutrients, has been linked to the development of NAFLD. Fructose not only contributes to hepatic steatosis but may trigger inflammatory signals as well. Polyunsaturated fatty acids are thought to exert anti-inflammatory effects. The role of vitamins as well as minerals in this field is actively being investigated. In this review, we discuss the evidence-linking macronutrients (such as carbohydrates and fat in general and fructose, fiber, short chain fatty acids, polyunsaturated fatty, and choline specifically) and micronutrients (such as vitamin E and C and minerals) with the development and treatment of NAFLD. We also discuss the literature on physical activity and NAFLD.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 50 条
  • [21] The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
    Moon, Jun Sung
    Yoon, Ji Sung
    Won, Kyu Chang
    Lee, Hyoung Woo
    DIABETES & METABOLISM JOURNAL, 2013, 37 (04) : 278 - 285
  • [22] Treatment of nonalcoholic fatty liver disease
    Suthat Liangpunsakul
    Naga Chalasani
    Current Treatment Options in Gastroenterology, 2003, 6 (6) : 455 - 463
  • [23] Treatment of nonalcoholic fatty liver disease
    Juergen Siebler
    Peter R Galle
    World Journal of Gastroenterology, 2006, (14) : 2161 - 2167
  • [24] Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
    Sophie Cazanave
    Alexei Podtelezhnikov
    Kristian Jensen
    Mulugeta Seneshaw
    Divya P. Kumar
    Hae-Ki Min
    Prasanna K. Santhekadur
    Bubu Banini
    Adolfo Gabriele Mauro
    Abdul M. Oseini
    Robert Vincent
    Keith Q. Tanis
    Andrea L. Webber
    Liangsu Wang
    Pierre Bedossa
    Faridoddin Mirshahi
    Arun J. Sanyal
    Scientific Reports, 10
  • [25] Treatment of nonalcoholic fatty liver disease
    Siebler, Juergen
    Galle, Peter R.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (14) : 2161 - 2167
  • [26] Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
    Nair, Bhagyalakshmi
    Nath, Lekshmi R.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2020, 40 (03) : 195 - 200
  • [27] Statin Use and Development and Progression of Nonalcoholic Fatty Liver Disease Based on Ultrasonography
    Feng, Baoyu
    Li, Fengde
    Lan, Yanqi
    Wang, Xiaomo
    Chen, Shuohua
    Yang, Chenlu
    Yin, Meihua
    Cui, Feipeng
    Wang, Guodong
    Zhou, Di
    Zhou, Yang
    Wu, Shutong
    Wang, Li
    Wu, Shouling
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [28] Risk prediction for the development and progression of nonalcoholic fatty liver disease with genetic markers
    Okanoue, Takeshi
    Shima, Toshihide
    Mizuno, Masayuki
    Mitsumoto, Yasuhide
    Kanbara, Yoshihiro
    Kawanaka, Miwa
    Kawaguchi, Takahisa
    Matsuda, Fumihiko
    HEPATOLOGY, 2017, 66 : 54A - 54A
  • [29] OSTEOPONTIN PROMOTES NONALCOHOLIC FATTY LIVER DISEASE PROGRESSION
    Syn, Wing-Kin
    Choi, Steve S.
    Liaskou, Evaggelia
    Karaca, Gamze F.
    Oo, Ye H.
    Pereira, Thiago A.
    Bhattacharya, Syamal D.
    Moylan, Cynthia A.
    Agboola, Kolade M.
    Omenetti, Alessia
    Schroder, Vanessa T.
    Mi, ZhiYong
    Guy, Cynthia D.
    Abdelmalek, Monal F.
    Potti, Anil
    Kuo, Paul C.
    Michelotti, Gregory A.
    Adams, David H.
    Diehl, Anna Mae
    HEPATOLOGY, 2010, 52 (04) : 350A - 351A
  • [30] What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
    Pan, Qin
    Xu, Qing-Yang
    Zhang, Lang-Hua
    He, Ya-Fang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (05)